Skip to main content

Table 2 The Clinical manifestations of patients with PSIL

From: Characterization of primary small intestinal lymphoma: a retrospective study based on double balloon endoscopy

 

DLBCL

indolent B-cell lymphoma

p value

DLBCL

T-cell lymphoma

p value

Abdominal pain (%)

4 (40.0)

8 (72.7)

0.198

4 (40.0)

6 (66.7)

0.370

Abdominal distension (%)

3 (30.0)

5 (45.5)

0.659

3 (30.0)

0 (0.0)

0.094

Diarrhea (%)

0 (0.0)

2 (18.2)

0.476

0 (0.0)

2 (22.2)

0.189

Abdominal discomfort (%)

0 (0.0)

3 (27.3)

0.214

0 (0.0)

1 (11.1)

0.450

Nausea and vomiting (%)

0 (0.0)

4 (36.4)

0.090

0 (0.0)

2 (22.2)

0.189

Intestinal obstruction (%)

2 (20.0)

3 (27.3)

1.000

2 (20.0)

0 (0.0)

0.479

Fever (%)

2 (20.0)

2 (18.2)

1.000

2 (20.0)

0 (0.0)

0.479

Night sweats (%)

2 (20.0)

2 (18.2)

1.000

2 (20.0)

0 (0.0)

0.479

Weight loss (%)

6 (60.0)

5 (45.5)

0.230

6 (60.0)

0 (0.0)

0.554

Fatigue (%)

2 (20.0)

2 (18.2)

1.000

2 (20.0)

0 (0.0)

0.479

B symptom

7 (70.0)

5 (45.5)

0.387

7 (70.0)

5 (55.6)

0.650

Melena (%)

3 (30.0)

4 (36.4)

1.000

3 (30.0)

0 (0.0)

0.218

Bloody stools (%)

1 (10.0)

0 (0.0)

0.476

1 (10.0)

1 (11.1)

1.000

Constipation (%)

4 (40.0)

6 (54.5)

0.670

4 (40.0)

1 (11.1)

0.319

Reduced exhaust defecation (%)

1 (10.0)

5 (45.5)

0.149

1 (10.0)

0 (0.0)

1.000

Fecal occult blood (%)

7 (70.0)

5 (45.5)

0.670

7 (70.0)

3 (33.3)

0.370